powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1821415704
Jacqueline Vaynkof
M.D.
Endocrinology
Manalapan,
NJ
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
99.0
Quality
98.4
Cost
78.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.01%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
63
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K
PRESCRIBING · PART D · 2024
Total Rx claims
4,281
Beneficiaries
—
Total drug cost
$2.2M
Distinct drugs
49
Brand share
60.9%
Top prescribed drugs
Semaglutide
431 claims
Levothyroxine Sodium
382 claims
Metformin Hcl
281 claims
Metformin Hcl
278 claims
Tirzepatide
270 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
8,137
Unique beneficiaries
—
Total services
18,213
Distinct HCPCS
53
Medicare payment
$414K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 290 Endocrinology providers in NJ — top quintile (cohort median 1,480).